Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell receptors (TCRs) recognizing MHC-presented Blattella germanica (German cockroach) allergen peptides are central to the pathogenesis of cockroach-induced allergic diseases (Oseroff et al., 2012, PMID: 22984187). These receptors are expressed on the surface of T lymphocytes and specifically bind to peptide fragments derived from major cockroach allergens, such as Bla g 1, Bla g 2, and Bla g 5, which are presented by Major Histocompatibility Complex (MHC) class II molecules (Pomés et al., 2017, PMID: 28135197). This interaction initiates a Th2-polarized immune response, characterized by the secretion of pro-inflammatory cytokines like IL-4 and IL-13, leading to IgE synthesis and airway hyperresponsiveness (Jeong et al., 2016, PMID: 27126153). In urban environments, exposure to these allergens is a significant risk factor for the development and severity of asthma. Therapeutic interventions targeting this TCR-MHC-peptide complex aim to modulate the immune system through allergen-specific immunotherapy, which seeks to desensitize the patient and induce long-term tolerance. Monitoring TCR specificity and MHC binding affinity is crucial for the design of effective peptide-based vaccines and personalized treatment regimens for cockroach-sensitive individuals.
Induction of immune tolerance through T-cell anergy, clonal deletion, or the promotion of regulatory T cells (Tregs) that suppress Th2-mediated allergic inflammation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor recognizing MHC-presented Blattella germanica allergen peptide (TCR-MHC-Bla g).